RTW INVESTMENTS, LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Allurion Technologies, Inc. 13D/A Amendment 13
ALURD · 02008G300
9.9% 9/2/2026
Event 8/31/2026
uniQure N.V. 13G
QURE · N90064101
5.7% 8/14/2026
Event 6/30/2026
Ultragenyx Pharmaceutical Inc. 13G
RARE · 90400D108
7.9% 8/14/2026
Event 6/30/2026
Tenax Therapeutics, Inc. 13G/A Amendment 3
TENX · 88032L605
9.9% 8/14/2026
Event 6/30/2026
Spyre Therapeutics, Inc. 13G/A Amendment 2
SYRE · 00773J202
4.8% 8/14/2026
Event 6/30/2026
RadNet, Inc. 13G/A Amendment 1
RDNT · 750491102
6.2% 8/14/2026
Event 6/30/2026
Oruka Therapeutics, Inc. 13G
ORKA · 687604108
5.2% 8/14/2026
Event 6/30/2026
Kailera Therapeutics, Inc. 13G
KLRA · 482931102
8.3% 8/14/2026
Event 6/30/2026
iRhythm Holdings, Inc. 13G/A Amendment 1
IRTC · 450056106
6.6% 8/14/2026
Event 6/30/2026
CG Oncology, Inc. 13G/A Amendment 1
CGON · 156944100
9.7% 8/14/2026
Event 6/30/2026
Allurion Technologies, Inc. 13D/A Amendment 12
ALURD · 02008G300
9.9% 7/23/2026
Event 7/21/2026
Verastem, Inc. 13G/A Amendment 3
VSTM · 92337C203
9.9% 5/15/2026
Event 3/31/2026
uniQure N.V. 13G/A Amendment 4
QURE · N90064101
4.1% 5/15/2026
Event 3/31/2026
Tenax Therapeutics, Inc. 13G/A Amendment 2
TENX · 88032L605
9.9% 5/15/2026
Event 3/31/2026
Taysha Gene Therapies, Inc. 13G/A Amendment 5
TSHA · 877619106
7.0% 5/15/2026
Event 3/31/2026
Tango Therapeutics, Inc. 13G
TNGX · 87583X109
9.3% 5/15/2026
Event 3/31/2026
Stoke Therapeutics, Inc. 13G/A Amendment 7
STOK · 86150R107
9.9% 5/15/2026
Event 3/31/2026
Replimune Group, Inc. 13G/A Amendment 1
REPL · 76029N106
8.9% 5/15/2026
Event 3/31/2026
Rapt Therapeutics, Inc. 13G/A Amendment 2
RAPT · 75382E208
0% 5/15/2026
Event 3/31/2026
Milestone Pharmaceuticals Inc. 13G/A Amendment 7
MIST · 59935V107
9.9% 5/15/2026
Event 3/31/2026
iRhythm Holdings, Inc. 13G
IRTC · 450056106
5.2% 5/15/2026
Event 3/31/2026
Immatics N.V. 13G/A Amendment 4
IMTX · N44445109
9.6% 5/15/2026
Event 3/31/2026
Erasca, Inc. 13G
ERAS · 29479A108
5.2% 5/15/2026
Event 3/31/2026
COMPASS Pathways plc 13G/A Amendment 2
CMPS · 20451W101
9.9% 5/15/2026
Event 3/31/2026
CG Oncology, Inc. 13G
CGON · 156944100
8.3% 5/15/2026
Event 3/31/2026
Century Therapeutics, Inc. 13G
IPSC · 15673T100
7.1% 5/15/2026
Event 3/31/2026
Celcuity Inc. 13G
CELC · 15102K100
6.3% 5/15/2026
Event 3/31/2026
Castle Biosciences, Inc. 13G/A Amendment 1
CSTL · 14843C105
9.3% 5/15/2026
Event 3/31/2026
Candel Therapeutics, Inc. 13G
CADL · 137404109
8.8% 5/15/2026
Event 3/31/2026
Beta Bionics, Inc. 13G/A Amendment 2
BBNX · 08659B102
4.5% 5/15/2026
Event 3/31/2026
Apellis Pharmaceuticals, Inc. 13G/A Amendment 1
APLS · 03753U106
2.9% 5/15/2026
Event 3/31/2026
Orchestra Biomed Holdings, Inc. 13D/A Amendment 7
OBIO · 68572M106
19.2% 4/29/2026
Event 4/27/2026
Allurion Technologies, Inc. 13D/A Amendment 11
ALUR · 02008G201
39.4% 3/2/2026
Event 2/26/2026
Orchestra Biomed Holdings, Inc. 13D/A Amendment 6
OBIO · 68572M106
19.7% 2/25/2026
Event 2/23/2026
Zai Lab Limited 13G
ZLAB · 98887Q104
6.3% 2/17/2026
Event 12/31/2025
Verastem, Inc. 13G/A Amendment 2
VSTM · 92337C203
9.9% 2/17/2026
Event 12/31/2025
uniQure N.V. 13G/A Amendment 3
QURE · N90064101
6.0% 2/17/2026
Event 12/31/2025
Tenax Therapeutics, Inc. 13G/A Amendment 1
TENX · 88032L605
9.9% 2/17/2026
Event 12/31/2025
Taysha Gene Therapies, Inc. 13G/A Amendment 4
TSHA · 877619106
8.3% 2/17/2026
Event 12/31/2025
SAB Biotherapeutics, Inc. 13G/A Amendment 2
SABS · 78397T202
3.2% 2/17/2026
Event 12/31/2025
Rapt Therapeutics, Inc. 13G/A Amendment 1
RAPT · 75382E208
5.9% 2/17/2026
Event 12/31/2025
RadNet, Inc. 13G
RDNT · 750491102
5.1% 2/17/2026
Event 12/31/2025
Protagonist Therapeutics, Inc 13G/A Amendment 6
PTGX · 74366E102
8.1% 2/17/2026
Event 12/31/2025
Oruka Therapeutics, Inc. 13G/A Amendment 1
ORKA · 687604108
4.3% 2/17/2026
Event 12/31/2025
Kalaris Therapeutics, Inc. 13G
KLRS · 482929106
5.7% 2/17/2026
Event 12/31/2025
Immatics N.V. 13G/A Amendment 3
IMTX · N44445109
8.5% 2/17/2026
Event 12/31/2025
Exagen Inc. 13G/A Amendment 6
XGN · 30068X103
4.9% 2/17/2026
Event 12/31/2025
Castle Biosciences, Inc. 13G
CSTL · 14843C105
7.2% 2/17/2026
Event 12/31/2025
Beta Bionics, Inc. 13G/A Amendment 1
BBNX · 08659B102
5.7% 2/17/2026
Event 12/31/2025
Apogee Therapeutics, Inc. 13G/A Amendment 1
APGE · 03770N101
4.9% 2/17/2026
Event 12/31/2025
Apellis Pharmaceuticals, Inc. 13G
APLS · 03753U106
6.1% 2/17/2026
Event 12/31/2025
Alector, Inc. 13G/A Amendment 1
ALEC · 014442107
0% 2/17/2026
Event 12/31/2025
Akero Therapeutics, Inc. 13G/A Amendment 4
AKRO · 00973Y108
0% 2/17/2026
Event 12/31/2025
Zai Lab Limited 13G/A Amendment 1
ZLAB · 98887Q104
2.1% 11/14/2025
Event 9/30/2025
Xencor Inc 13G
XNCR · 98401F105
8.7% 11/14/2025
Event 9/30/2025
uniQure N.V. 13G/A Amendment 2
QURE · N90064101
7.2% 11/14/2025
Event 9/30/2025
Replimune Group, Inc. 13G
REPL · 76029N106
8.2% 11/14/2025
Event 9/30/2025
Milestone Pharmaceuticals Inc. 13G/A Amendment 6
MIST · 59935V107
9.9% 11/14/2025
Event 9/30/2025
Merus N.V. 13G/A Amendment 1
MRUS · N5749R100
2.7% 11/14/2025
Event 9/30/2025
Immatics N.V. 13G/A Amendment 2
IMTX · N44445109
7.3% 11/14/2025
Event 9/30/2025
Cargo Therapeutics, Inc. 13G/A Amendment 3
CRGX · 14179K101
0% 11/14/2025
Event 9/30/2025
Aquestive Therapeutics, Inc. 13G
AQST · 03843E104
5.2% 11/14/2025
Event 9/30/2025
Alector, Inc. 13G
ALEC · 014442107
6.9% 11/14/2025
Event 9/30/2025
Acadia Pharmaceuticals Inc. 13G/A Amendment 3
ACAD · 004225108
4.2% 11/14/2025
Event 9/30/2025
Allurion Technologies, Inc. 13D/A Amendment 10
ALUR · 02008G201
48.1% 11/13/2025
Event 11/11/2025
Allurion Technologies, Inc. 13D/A Amendment 9
ALUR · 02008G201
43.6% 11/7/2025
Event 11/5/2025
Avidity Biosciences, Inc. 13D/A Amendment 5
RNAM · 05370A108
3.1% 10/29/2025
Event 10/27/2025
COMPASS Pathways plc 13G/A Amendment 1
CMPS · 20451W101
9.9% 8/14/2025
Event 6/30/2025
Compass Therapeutics, Inc. 13G/A Amendment 1
CMPS · 20451W101
0% 8/14/2025
Event 6/30/2025
Zai Lab Limited 13G
ZLAB · 98887Q104
5.1% 8/14/2025
Event 6/30/2025
Verastem, Inc. 13G/A Amendment 1
VSTM · 92337C203
9.9% 8/14/2025
Event 6/30/2025
uniQure N.V. 13G/A Amendment 1
QURE · N90064101
9.4% 8/14/2025
Event 6/30/2025
Taysha Gene Therapies, Inc. 13G/A Amendment 3
TSHA · 877619106
9.9% 8/14/2025
Event 6/30/2025
Tarsus Pharmaceuticals, Inc. 13G/A Amendment 5
TARS · 87650L103
8.1% 8/14/2025
Event 6/30/2025
Exagen Inc. 13G/A Amendment 5
XGN · 30068X103
7.7% 8/14/2025
Event 6/30/2025
Compass Therapeutics, Inc. 13G/A Amendment 1
CMPS · 20451W101
9.9% 8/14/2025
Event 6/30/2025
Cargo Therapeutics, Inc. 13G/A Amendment 2
CRGX · 14179K101
6.4% 8/14/2025
Event 6/30/2025
Axsome Therapeutics, Inc. 13G/A Amendment 4
AXSM · 05464T104
3.1% 8/14/2025
Event 6/30/2025
Akero Therapeutics, Inc. 13G/A Amendment 3
AKRO · 00973Y108
7.3% 8/14/2025
Event 6/30/2025
Orchestra Biomed Holdings, Inc. 13D/A Amendment 5
OBIO · 68572M106
15.4% 8/6/2025
Event 8/4/2025
Tenax Therapeutics, Inc. 13G
TENX · 88032L605
10.0% 5/15/2025
Event 3/31/2025
89bio, Inc. 13G/A Amendment 2
ETNB · 282559103
1.3% 5/15/2025
Event 3/31/2025
GH Research PLC 13G/A Amendment 1
GHRS · G3855L106
8.9% 5/15/2025
Event 3/31/2025
PepGen Inc. 13G/A Amendment 1
PEPG · 713317105
0% 5/15/2025
Event 3/31/2025
Dyne Therapeutics, Inc. 13G/A Amendment 2
DYN · 26818M108
1.5% 5/15/2025
Event 3/31/2025
Beta Bionics, Inc. 13G
BBNX · 08659B102
7.6% 5/15/2025
Event 3/31/2025
Axsome Therapeutics, Inc. 13G/A Amendment 3
AXSM · 05464T104
6.0% 5/15/2025
Event 3/31/2025
Verastem, Inc. 13G
VSTM · 92337C203
8.3% 5/15/2025
Event 3/31/2025
Immunic, Inc. 13G/A Amendment 4
IMUX · 4525EP101
1.1% 5/15/2025
Event 3/31/2025
Taysha Gene Therapies, Inc. 13G/A Amendment 2
TSHA · 877619106
10.0% 5/15/2025
Event 3/31/2025
Oruka Therapeutics, Inc. 13G
ORKA · 687604108
5.2% 5/15/2025
Event 3/31/2025
Rapt Therapeutics, Inc. 13G
RAPT · 75382E109
8.9% 5/15/2025
Event 3/31/2025
uniQure N.V. 13G
QURE · N90064101
7.9% 5/15/2025
Event 3/31/2025
COMPASS Pathways plc 13G
CMPS · 20451W101
8.3% 5/15/2025
Event 3/31/2025
Orchestra Biomed Holdings, Inc. 13D/A Amendment 4
OBIO · 68572M106
21.7% 5/1/2025
Event 4/29/2025
Allurion Technologies, Inc. 13D/A Amendment 8
ALUR · 02008G201
34.1% 4/17/2025
Event 4/15/2025
Allurion Technologies, Inc. 13D/A Amendment 7
ALUR · 02008G102
17.6% 2/24/2025
Event 2/20/2025
Stoke Therapeutics, Inc. 13G/A Amendment 6
STOK · 86150R107
10.0% 2/14/2025
Event 12/31/2024
Akero Therapeutics, Inc. 13G/A Amendment 2
AKRO · 00973Y108
9.8% 2/14/2025
Event 12/31/2024
Acadia Pharmaceuticals Inc. 13G/A Amendment 2
ACAD · 004225108
5.2% 2/14/2025
Event 12/31/2024